Related Experiment Video
Updated: Aug 2, 2026
09:23
Isolation of Microvascular Endothelial Tubes from Mouse Resistance Arteries
Published on: November 25, 2013
Can Lester Jones tubes be tolerated for decades?
R L Scawn1, D H Verity1, G E Rose1
1Ophthalmology, Adnexal Service, Moorfields Eye Hospital NHS Foundation Trust, London, UK.
Eye (London, England)
|August 19, 2017
Summary
Jones tubes, a type of canalicular bypass tube, can last for decades. Some patients maintain their original Jones tube for over 30 years with proper care, offering insights into long-term device expectations.
Area of Science:
- Ophthalmology
- Oculoplastics
- Tear Drainage Surgery
Background:
- Canalicular bypass tubes, such as Jones tubes, are used to treat nasolacrimal duct obstruction.
- Lester Jones described these tubes approximately 50 years ago.
Purpose of the Study:
- To evaluate the long-term outcomes and durability of Jones tubes placed decades ago.
- To provide data for counseling patients on the expected lifespan of bypass tubes.
Main Methods:
- Retrospective review of living patients who had Jones tube placement between 1969 and 1989.
- Analysis of tube duration, replacement frequency, and patient outcomes at last follow-up within the last 15 years.
Main Results:
- 33 eyes from 29 patients with Jones tubes placed before 1990 were reviewed, with an average follow-up of 29.5 years.
- The original Jones tube remained functional in 24% of eyes at a mean of 34 years.
- 11% of eyes lost their tubes, with most experiencing minimal symptoms.
Conclusions:
- Jones tubes can be tolerated for over four decades, demonstrating significant long-term efficacy.
- Some patients can retain their originally placed Jones tube for life with appropriate maintenance.
- This study offers valuable data for patient counseling regarding the longevity of canalicular bypass devices.
Related Concept Videos
01:11Aryldiazonium Salts to Azo Dyes: Diazo Coupling
The reaction of weakly electrophilic aryldiazonium (also called arenediazonium) salts with highly activated aromatic compounds leads to the formation of products with an —N=N— link, called an azo linkage. This reaction, presented in Figure 1, is known as diazo coupling and occurs without the loss of the nitrogen atoms of the aryldiazonium salt. Highly activated aromatic compounds such as phenols or arylamines favor the diazo coupling reaction. The coupling generally occurs at the para position.
01:15Drug Elimination by Renal Route: Tubular Secretion
Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
01:19Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
01:19Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
01:28Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
01:26Oral Drug Delivery Systems: Continuous-Release Systems
Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...